Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
4 trials
Recent
Start date
Enrollment
INDUSTRY
×
Leukemia, Myeloid, Chronic-Phase
×
asciminib
×
Clear all
Filters
3
NCT03874858
2026-04-02
DANTE
Novartis
Phase 2
Completed
124 enrolled
NCT04666259
2025-10-16
AIM4CML
Novartis
Phase 3
Completed
56 enrolled
18 charts
NCT05384587
2025-10-14
ASC2ESCALATE
Novartis
Phase 2
Active not recruiting
34 enrolled
NCT07091019
2025-07-29
ASC4REAL-2
Novartis
Not yet recruiting
1,000 enrolled